Below is an excerpt from clinicaltrials.gov giving details of the test criteria for the H1N1 flu vaccine to be used on pregnant women. When you look at this you will notice some alarming facts
H1N1 Vaccine in Pregnant Women
This study is ongoing, but not recruiting participants.
First Received: August 20, 2009 Last Updated: October 22, 2009 History of Changes
Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00963430
This purpose of this study is to evaluate an investigational 2009 H1N1 influenza vaccine to determine vaccine safety in pregnant women and how the body reacts to different strengths of the H1N1 influenza vaccine. In this study 2 strengths of the H1N1 influenza vaccine will be tested (given 3 weeks apart). Participants will include approximately 120 healthy pregnant women, ages 18-39 years, in their second or third trimester of pregnancy (14-34 weeks gestation). Study procedures will include 2 doses of vaccine, blood samples, cord blood samples at delivery, and recording temperature and vaccine side effects in a memory aid for 8 days following each vaccination. Participants will be involved in study related procedures for about 7 months.
Condition Intervention Phase
Influenza Biological: Inactivated H1N1 Vaccine Phase II
Study Type: Interventional
Study Design: Prevention, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Parallel Assignment, Safety/Efficacy Study
Official Title: A Phase II Study in Pregnant Women to Assess the Safety and Immunogenicity of an Unadjuvanted Sanofi Pasteur H1N1 Inactivated Influenza Vaccine Administered at Two Dose Levels
Resource links provided by NLM:
MedlinePlus related topics: Flu
U.S. FDA Resources
Further study details as provided by National Institute of Allergy and Infectious Diseases (NIAID):
Estimated Enrollment: 120
Study Start Date: September 2009
Estimated Study Completion Date: July 2010
Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
This is the opening summary from the following website
So what are the alarming issues here?
1 The government trials on the safety of the H1N1 vaccine on pregnant women were not due to be completed until July 2010 yet they are being rolled out now
2 The flu vaccine being tested contains NO adjuvants, unlike the vaccine being used on the public which contains mercury, aluminium, squalene etc
3 The vaccines tested contain inactivated virus whereas the flumist version contains live attenuated H!N! virus
This is all shocking enough but it gets worse when you see what is going on in the media. No tests have been completed, nor will they be any time soon yet the media doctors are lying straight into the camera to the audience of pregnant women and telling them that these vaccines are known to be safe
HOW DO THEY KNOW WHEN NO TESTS HAVE BEEN COMPLETED ?